SJS Investment Consulting’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
841
-27
-3% -$10K 0.04% 118
2026
Q1
$254K Buy
868
+166
+24% +$54.6K 0.03% 127
2025
Q4
$246K Buy
702
+14
+2% +$4.73K 0.03% 122
2025
Q3
$222K Buy
688
+11
+2% +$3.42K 0.03% 124
2025
Q2
$263K Sell
677
-41
-6% -$16.5K 0.04% 85
2025
Q1
$312K Buy
718
+34
+5% +$13.6K 0.05% 72
2024
Q4
$252K Sell
684
-6
-0.9% -$2.51K 0.04% 80
2024
Q3
$359K Sell
690
-1
-0.1% -$534 0.06% 65
2024
Q2
$374K Hold
691
0.07% 59
2024
Q1
$358K Sell
691
-1
-0.1% -$497 0.07% 58
2023
Q4
$326K Sell
692
-1,948
-74% -$901K 0.07% 61
2023
Q3
$1.15M Buy
2,640
+5
+0.2% +$2.27K 0.29% 28
2023
Q2
$1.17M Buy
2,635
+1
+0% +$461 0.29% 27
2023
Q1
$1.21M Sell
2,634
-9
-0.3% -$4.28K 0.33% 26
2022
Q4
$1.36M Buy
2,643
+1,958
+286% +$994K 0.4% 20
2022
Q3
$312K Buy
+685
New +$328K 0.11% 55
2022
Q1
$336K Buy
684
+8
+1% +$3.66K 0.1% 65
2021
Q4
$313K Buy
+676
New +$284K 0.09% 69

Other funds holding ELV

SJS Investment Consulting's ELV Position: Q2 2026 in Review

SJS Investment Consulting reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $10K and leaving 841 shares worth $325K. The position accounts for 0.04% of the portfolio, ranked #118.

SJS Investment Consulting first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.36M in Q4 2022. 513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • SJS Investment Consulting held 841 shares of Elevance Health worth $325K as of Q2 2026.
  • SJS Investment Consulting sold 27 Elevance Health shares in Q2 2026, an estimated $10K.
  • Elevance Health made up 0.04% of SJS Investment Consulting's portfolio in Q2 2026, its #118 holding.
  • SJS Investment Consulting first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • SJS Investment Consulting's Elevance Health position peaked at $1.36M in Q4 2022.
  • 513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.